As of 2025-09-16, the Relative Valuation of Rigel Pharmaceuticals Inc (RIGL) is 38.30 USD. This relative valuation is based on P/E multiples. With the latest stock price at 37.30 USD, the upside of Rigel Pharmaceuticals Inc based on Relative Valuation is 2.7%.
The range of the Relative Valuation is 16.24 - 66.74 USD.
| Range | Selected | |
| Trailing P/E multiples | 8.2x - 12.2x | 10.2x |
| Forward P/E multiples | 16.8x - 26.5x | 21.6x |
| Fair Price | 16.24 - 66.74 | 38.30 |
| Upside | -56.5% - 78.9% | 2.7% |
| Date | P/E |
| 2025-09-12 | 6.96 |
| 2025-09-11 | 6.94 |
| 2025-09-10 | 6.69 |
| 2025-09-09 | 6.59 |
| 2025-09-08 | 7.50 |
| 2025-09-05 | 7.58 |
| 2025-09-04 | 7.36 |
| 2025-09-03 | 7.26 |
| 2025-09-02 | 7.05 |
| 2025-08-29 | 7.12 |
| 2025-08-28 | 7.21 |
| 2025-08-27 | 7.29 |
| 2025-08-26 | 7.63 |
| 2025-08-25 | 7.47 |
| 2025-08-22 | 7.61 |
| 2025-08-21 | 7.70 |
| 2025-08-20 | 7.59 |
| 2025-08-19 | 7.14 |
| 2025-08-18 | 7.35 |
| 2025-08-15 | 7.25 |
| 2025-08-14 | 6.95 |
| 2025-08-13 | 6.71 |
| 2025-08-12 | 6.33 |
| 2025-08-11 | 6.14 |
| 2025-08-08 | 5.81 |
| 2025-08-07 | 5.58 |
| 2025-08-06 | 5.47 |
| 2025-08-05 | 4.45 |
| 2025-08-04 | 4.16 |
| 2025-08-01 | 4.02 |
| 2025-07-31 | 3.86 |
| 2025-07-30 | 3.85 |
| 2025-07-29 | 3.65 |
| 2025-07-28 | 3.67 |
| 2025-07-25 | 3.70 |
| 2025-07-24 | 3.75 |
| 2025-07-23 | 3.86 |
| 2025-07-22 | 3.68 |
| 2025-07-21 | 3.59 |
| 2025-07-18 | 3.45 |
| 2025-07-17 | 3.47 |
| 2025-07-16 | 3.54 |
| 2025-07-15 | 3.47 |
| 2025-07-14 | 3.55 |
| 2025-07-11 | 3.46 |
| 2025-07-10 | 3.59 |
| 2025-07-09 | 3.49 |
| 2025-07-08 | 3.38 |
| 2025-07-07 | 3.46 |
| 2025-07-03 | 3.47 |